Where A REMS Didn't Help: Sanofi Must Deal With Liver Injuries With Multaq
This article was originally published in The Pink Sheet Daily
Executive Summary
Company has sent a "Dear Dr." letter describing rare cases of liver problems and will also send additional data to FDA from the clinical trials.